phentolamine has been researched along with Causalgia in 5 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
Causalgia: A complex regional pain syndrome characterized by burning pain and marked sensitivity to touch (HYPERESTHESIA) in the distribution of an injured peripheral nerve. Autonomic dysfunction in the form of sudomotor (i.e., sympathetic innervation to sweat glands), vasomotor, and trophic skin changes may also occur. (Adams et al., Principles of Neurology, 6th ed, p1359)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of our study was to clarify whether the phentolamine test is as suitable as sympathetic blockade in diagnosing cases of sympathetically maintained pain." | 9.10 | [Sympathetically maintained pain (SMP): phentolamine test vs sympathetic nerve blockade. Comparison of two diagnostic methods]. ( Kohn, D; Larsen, B; Müller, B; Wehnert, Y, 2002) |
| "Chronic neurogenic facial pain is commonly resistant to treatment and is often the source of significant patient morbidity." | 6.69 | Chronic neurogenic facial pain: lack of response to intravenous phentolamine. ( Chaudry, A; Keith, DA; Maciewicz, RJ; Scrivani, SJ, 1999) |
| "The objective of our study was to clarify whether the phentolamine test is as suitable as sympathetic blockade in diagnosing cases of sympathetically maintained pain." | 5.10 | [Sympathetically maintained pain (SMP): phentolamine test vs sympathetic nerve blockade. Comparison of two diagnostic methods]. ( Kohn, D; Larsen, B; Müller, B; Wehnert, Y, 2002) |
| "Chronic neurogenic facial pain is commonly resistant to treatment and is often the source of significant patient morbidity." | 2.69 | Chronic neurogenic facial pain: lack of response to intravenous phentolamine. ( Chaudry, A; Keith, DA; Maciewicz, RJ; Scrivani, SJ, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wehnert, Y | 1 |
| Müller, B | 1 |
| Larsen, B | 1 |
| Kohn, D | 1 |
| Na, HS | 1 |
| Leem, JW | 1 |
| Chung, JM | 1 |
| Breivik, H | 1 |
| Schott, GD | 1 |
| Scrivani, SJ | 1 |
| Chaudry, A | 1 |
| Maciewicz, RJ | 1 |
| Keith, DA | 1 |
2 trials available for phentolamine and Causalgia
| Article | Year |
|---|---|
[Sympathetically maintained pain (SMP): phentolamine test vs sympathetic nerve blockade. Comparison of two diagnostic methods].
Topics: Adrenergic alpha-Antagonists; Adult; Autonomic Nerve Block; Causalgia; Complex Regional Pain Syndrom | 2002 |
Chronic neurogenic facial pain: lack of response to intravenous phentolamine.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Anesthetics, Local; Causalgia; Chronic Disease; Facial Pa | 1999 |
3 other studies available for phentolamine and Causalgia
| Article | Year |
|---|---|
Abnormalities of mechanoreceptors in a rat model of neuropathic pain: possible involvement in mediating mechanical allodynia.
Topics: Afferent Pathways; Animals; Causalgia; Hindlimb; Male; Mechanoreceptors; Nociceptors; Pain Threshold | 1993 |
Chronic pain and the sympathetic nervous system.
Topics: Autonomic Nervous System Diseases; Causalgia; Chronic Disease; Clinical Trials as Topic; Double-Blin | 1997 |
Interrupting the sympathetic outflow in causalgia and reflex sympathetic dystrophy.
Topics: Autonomic Nerve Block; Causalgia; Guanethidine; Humans; Meta-Analysis as Topic; Pain; Phentolamine; | 1998 |